Covered recipient · General Payments record
DEBRA K LEVIN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$7,597.86
- Reported across 147 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $502.49 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $211.04 | 3 |
| Acerta Pharma LLC | $152.31 | 4 |
| Lilly USA, LLC | $68.19 | 3 |
| ABBVIE INC. | $36.84 | 1 |
| PFIZER INC. | $17.94 | 1 |
| Merck Sharp & Dohme Corporation | $16.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $36.84 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104165720 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.41 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105516993 | CMS |
| AstraZeneca Pharmaceuticals LP | $109.74 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104458402 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.55 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104284615 | CMS |
| AstraZeneca Pharmaceuticals LP | $5.61 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104409313 | CMS |
| Lilly USA, LLC | $27.40 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136138933 | CMS |
| Lilly USA, LLC | $21.55 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136147409 | CMS |
| Lilly USA, LLC | $19.24 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136132550 | CMS |
| Merck Sharp & Dohme LLC | $16.17 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141727382 | CMS |
| Novo Nordisk Inc | $24.12 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096647299 | CMS |
| Novo Nordisk Inc | $116.31 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097416631 | CMS |
| Novo Nordisk Inc | $70.61 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097245004 | CMS |
| PFIZER INC. | $17.94 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131940673 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.